Literature DB >> 21763079

Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease.

R E Molokie1, Z J Wang, D J Wilkie.   

Abstract

Less than 20 years after Herrick described the first case, the cold was proposed as having a role in precipitating pain in sickle cell disease. Numerous publications focus on weather changes, in particular exposure to the cold, and their association with vaso-occlusive (painful) episodes. Whereas several theories have been proposed to explain the association, a plausible hypothesis based on our current understanding of the pathophysiology of pain has not been offered. We hypothesize that the pain evoked by these weather changes are allodyinic (pain with stimulus not typically painful) and hyperalgesic (heightened pain with painful stimulus) responses due to the presence of neuropathic pain. This hypothesis represents a paradigm shift in understanding, as well as explaining at least some of the pain experience in sickle cell disease, and should be the impetus to further determine the characteristics of those patients who develop allodynia and hyperalgesia to cold weather. Whereas some researchers have suggested that those with sickle cell disease may have neuropathic pain, including a report from our own ongoing study [1], it has not been well accepted nor has it been applied in understanding pain associated with sickle cell disease. The conceptual shift and new understanding is important to develop preventive strategies, apply pain therapies new to the sickle cell population, and view pain in sickle cell disease in the context of a chronic disease. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21763079      PMCID: PMC3701405          DOI: 10.1016/j.mehy.2011.06.018

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  33 in total

1.  Menstrual pattern in women with sickle cell anaemia and its association with sickling crises.

Authors:  W C Yoong; S M Tuck
Journal:  J Obstet Gynaecol       Date:  2002-07       Impact factor: 1.246

2.  Assessment of painful episode frequency in sickle-cell disease.

Authors:  M P Westerman; K Bailey; S Freels; R Schlegel; P Williamson
Journal:  Am J Hematol       Date:  1997-03       Impact factor: 10.047

3.  Non-seasonality of sickle-cell crisis.

Authors:  R A Seeler
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

Review 4.  NeuPSIG guidelines on neuropathic pain assessment.

Authors:  Maija Haanpää; Nadine Attal; Miroslav Backonja; Ralf Baron; Michael Bennett; Didier Bouhassira; Giorgio Cruccu; Per Hansson; Jennifer A Haythornthwaite; Gian Domenico Iannetti; Troels S Jensen; Timo Kauppila; Turo J Nurmikko; Andew S C Rice; Michael Rowbotham; Jordi Serra; Claudia Sommer; Blair H Smith; Rolf-Detlef Treede
Journal:  Pain       Date:  2010-09-19       Impact factor: 6.961

5.  A chronology of pain and comfort in children with sickle cell disease.

Authors:  J E Beyer; L E Simmons; G M Woods; P M Woods
Journal:  Arch Pediatr Adolesc Med       Date:  1999-09

6.  Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate.

Authors:  Naresh Kumar; Andre Laferriere; Jonathan S C Yu; Amelia Leavitt; Terence J Coderre
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

7.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.

Authors:  Susan M Carlton; Junhui Du; Huai Yu Tan; Olivera Nesic; Gregory L Hargett; Anne C Bopp; Ammar Yamani; Qing Lin; William D Willis; Claire E Hulsebosch
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

Review 8.  Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.

Authors:  F M Gill; L A Sleeper; S J Weiner; A K Brown; R Bellevue; R Grover; C H Pegelow; E Vichinsky
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

9.  Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.

Authors:  Wally R Smith; Robert L Bauserman; Samir K Ballas; William F McCarthy; Martin H Steinberg; Paul S Swerdlow; Myron A Waclawiw; Bruce A Barton
Journal:  Pain       Date:  2009-08-14       Impact factor: 6.961

10.  Risk of altitude exposure in sickle cell disease.

Authors:  S Claster; M J Godwin; S H Embury
Journal:  West J Med       Date:  1981-11
View more
  13 in total

1.  Ecological momentary assessment of HIV versus reproductive health symptoms in women of differing reproductive stages living with HIV.

Authors:  Rebecca Schnall; Jianfang Liu; Nancy Reame
Journal:  Menopause       Date:  2019-12       Impact factor: 2.953

2.  Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Cherese Pullum; Judith M Schlaeger; Roger B Fillingim; Diana J Wilkie
Journal:  Pain Pract       Date:  2015-01-12       Impact factor: 3.183

3.  Transient receptor potential polymorphism and haplotype associate with crisis pain in sickle cell disease.

Authors:  Ellie H Jhun; Xiaoyu Hu; Nilanjana Sadhu; Yingwei Yao; Ying He; Diana J Wilkie; Robert E Molokie; Zaijie J Wang
Journal:  Pharmacogenomics       Date:  2018-04-05       Impact factor: 2.533

4.  Relationship of Pain Quality Descriptors and Quantitative Sensory Testing: Sickle Cell Disease.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Nurs Res       Date:  2019 Sep/Oct       Impact factor: 2.381

5.  Sensitivities to Thermal and Mechanical Stimuli: Adults With Sickle Cell Disease Compared to Healthy, Pain-Free African American Controls.

Authors:  Robert E Molokie; Zaijie J Wang; Yingwei Yao; Keesha L Powell-Roach; Judith M Schlaeger; Marie L Suarez; David A Shuey; Veronica Angulo; Jesus Carrasco; Miriam O Ezenwa; Roger B Fillingim; Diana J Wilkie
Journal:  J Pain       Date:  2019-11-13       Impact factor: 5.820

6.  Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.

Authors:  Keesha Powell-Roach; Yingwei Yao; Miriam O Ezenwa; Judith M Schlaeger; Marie L Suarez; Robert E Molokie; Zaijie Jim Wang; Diana J Wilkie
Journal:  West J Nurs Res       Date:  2019-03-22       Impact factor: 1.967

Review 7.  Spinal and afferent PKC signaling mechanisms that mediate chronic pain in sickle cell disease.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Neurosci Lett       Date:  2019-04-30       Impact factor: 3.046

8.  Glucocorticoid receptor single nucleotide polymorphisms are associated with acute crisis pain in sickle cell disease.

Authors:  Ellie H Jhun; Nilanjana Sadhu; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Pharmacogenomics       Date:  2018-08-06       Impact factor: 2.533

9.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

10.  Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.

Authors:  Ellie Jhun; Ying He; Yingwei Yao; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Anesth Analg       Date:  2014-11       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.